Hoàng Thị, Hà, and Phương Phạm Cẩm. “THE RESULTS OF GEFTINIB AS THE FIRST-LINE TREATMENT OF ADVANCED NON-SMALL CELL LUNG CANCER PATIENTS HARBORING EGFR MUTATIONS”. Vietnam Medical Journal, vol. 551, no. 3, July 2025, doi:10.51298/vmj.v551i3.14682.